Welsh Labour Leader visits Creo's design and manufacturing facilities in Chepstow

Creo Medical was pleased to welcome Vaughan Gething MS, the Welsh Labour leader and colleagues, to our design and manufacturing facilities in Chepstow.

During the visit Creo was able to showcase its pioneering endoscopic surgical solutions, which introduce advanced energy to endoscopy in new markets and procedures, facilitating an array of benefits to patients, clinicians and healthcare providers. Creo is an Innovation-led Welsh company, rolling out cutting-edge medical technology that utilises high-frequency microwave energy and dynamic matching techniques for cancer treatment. Creo's technology can be used to treat Bowel, Oesophagus, Stomach, Lung, Pancreas, Liver cancer, whilst reducing waiting times and hospital backlog at a lower cost than traditional surgical procedures and treatments.

Vaughan Gething, who is set to be confirmed as the First Minister of Wales later this week, visited the site in his capacity as Leader of the Welsh Labour Party, along with Jo Stevens, MP for Cardiff Central; Shadow Secretary of State for Wales; and Catherine Fookes, Labour parliamentary candidate for Monmouthshire. Vaughan Gething previously visited Creo Medical's Chepstow Headquarters in his capacity as Economy Minister in 2023.

The presentation delivered at yesterday's meeting is available to view on Creo Medical's reports and presentations page.

The Welsh Government provided support to the business via its Economy Futures Fund, to create 85 jobs while expanding its premises and investing in state-of-the-art manufacturing equipment.

The Development Bank of Wales have also been strong supporters of the business and remains a significant shareholder of the Company. Creo has also received considerable support from local Angel Investors and UK Institutional Investors. These investments have allowed Creo to grow its workforce, creating well paid jobs in Chepstow.

Craig Gulliford, Chief Executive Officer of Creo, commented:

"Creo is a great example of a dynamic Welsh business at the very forefront of Medtech device innovation, developing pioneering surgical devices that are being rolled out globally, and transforming the way in which cancer can be treated. We welcome the Welsh Government's continued support for our business and have been delighted to demonstrate to the Welsh Labour Party leader, The Shadow Secretary of State for Wales, and colleagues, the exciting opportunity we have as a Welsh business to become a world-leader in this emerging field of endoscopic surgery."

Shadow Secretary of State for Wales, Jo Stevens MP said: 

"Creo Medical is a fantastic example of how the Welsh Labour government is backing home-grown businesses to create well paid, skilled jobs.

"Their ground-breaking medtech innovations transform the surgical experience for clinicians and patients. Welsh Government support has allowed them to grow their business creating new, well-paid jobs here in Wales. 

"With a Labour government at both ends of the M4, we will get our economy growing and modernise our NHS."

Posted 19/03/2024

For press enquiries please contact media@creomedical.com. For all other enquiries please visit our Contact page.

Further news

15 May 2024

Full results - Final Results Strong revenue growth and significant commercial progress (9th May 2024)

Read

13 May 2024

Directorate Changes - May 2024

Read

07 May 2024

Creo Medical receives King’s Award for Enterprise in Innovation

Read

02 May 2024

MicroBlate Flex in new clinical trial at Royal Brompton Hospital

Read

24 April 2024

NHS Supply Chain real-world data demonstrates substantial cash savings

Read

05 February 2024

Strategic Collaboration with Khalifa University of Science and Technology, Abu Dhabi

Read

31 January 2024

Roll-out of Speedboat® UltraSlim reaches Asia Pacific

Read

10 January 2024

First Use of Speedboat® UltraSlim in Latin America

Read

13 December 2023

First European Speedboat® UltraSlim procedure marks early commercial launch

Read

01 November 2023

Speedboat® UltraSlim: US FDA Clearance

Read